HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges

BACKGROUND: Sickle cell disease (SCD) is a neglected burden of growing importance. >312,000 births are affected annually by sickle cell anaemia (SCA). Early interventions such as newborn screening, penicillin prophylaxis and hydroxyurea can substantially reduce the mortality and morbidity associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nnodu, Obiageli, Isa, Hezekiah, Nwegbu, Maxwell, Ohiaeri, Chinatu, Adegoke, Samuel, Chianumba, Reuben, Ugwu, Ngozi, Brown, Biobele, Olaniyi, John, Okocha, Emmanuel, Lawson, Juliet, Hassan, Abdul-Aziz, Diaku-Akinwumi, Ijeoma, Madu, Anazoeze, Ezenwosu, Osita, Tanko, Yohanna, Kangiwa, Umar, Girei, Ahmed, Israel-Aina, Yetunde, Ladu, Adama, Egbuzu, Perpetua, Abjah, Usman, Okolo, Angela, Akbulut-Jeradi, Nagihan, Fernandez, Maria, Piel, Frédéric B., Adekile, Adekunle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692636/
https://www.ncbi.nlm.nih.gov/pubmed/30773433
http://dx.doi.org/10.1016/j.bcmd.2019.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692636/
https://www.ncbi.nlm.nih.gov/pubmed/30773433
http://dx.doi.org/10.1016/j.bcmd.2019.01.007

Ejemplares similares